carbostyril has been researched along with T-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alonso-Alonso, R; Burrows, F; Esteve-Codina, A; Fuste, B; García-Diaz, N; Gualberto, A; Gut, M; Martínez, N; Merino, D; Mondéjar, R; Pérez, C; Piris, MÁ; Rodríguez, M; Scholz, C; Vaqué, JP | 1 |
1 other study(ies) available for carbostyril and T-Cell Lymphoma
Article | Year |
---|---|
Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma.
Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Inhibitory Concentration 50; Lymphoma, T-Cell; Mutation; Phenotype; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Quinolones; Signal Transduction; T-Lymphocytes | 2020 |